|
|
Previous Article | Table of Contents | Next Article 
Leukemia translocation gene, PLZF, is expressed with a speckled nuclear
pattern in early hematopoietic progenitors
A Reid, A Gould, N Brand, M Cook, P Strutt, J Li, J Licht, S Waxman, R Krumlauf and A Zelent
Leukaemia Research Fund Centre at the Institute of Cancer Research, London,
UK.
The PLZF gene was discovered by studying a rearrangement of the RAR alpha
locus in a patient with acute promyelocytic leukemia and a t(11;17)
chromosomal translocation. To understand further the potential role(s) of
the PLZF gene product in hematopoiesis, we have examined its expression
levels in a variety of murine tissues and in established cell lines that
are representative of various stages of myeloid and lymphoid development.
We show that murine PLZF(mPLZF) is expressed at the highest levels in
undifferentiated, multipotential hematopoietic progenitor cells and that
its expression declines as cells become more mature and committed to
various hematopoietic lineages. Data obtained with established cell lines
are corroborated by results showing the lack of human PLZF protein
expression in mature peripheral blood mononuclear cells and high PLZF
levels in the nuclei of CD34+ human bone marrow progenitor cells.
Interestingly, unlike many transcription factors, PLZF protein in these
cells possesses distinct punctate nuclear distribution, suggesting its
compartmentalization in the nucleus. Taken together, our data suggest a
role for PLZF protein in early hematopoiesis and the requirement of
downregulation of its expression for proper differentiation of most
hematopoietic lineages.
Volume 86,
Issue 12,
pp. 4544-4552,
12/15/1995
Copyright © 1995 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Doulatov, F. Notta, K. L. Rice, L. Howell, A. Zelent, J. D. Licht, and J. E. Dick
PLZF is a regulator of homeostatic and cytokine-induced myeloid development
Genes & Dev.,
September 1, 2009;
23(17):
2076 - 2087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Elkabetz, G. Panagiotakos, G. Al Shamy, N. D. Socci, V. Tabar, and L. Studer
Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage
Genes & Dev.,
January 15, 2008;
22(2):
152 - 165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Denne, M. Sauter, V. Armbruester, J. D. Licht, K. Roemer, and N. Mueller-Lantzsch
Physical and Functional Interactions of Human Endogenous Retrovirus Proteins Np9 and Rec with the Promyelocytic Leukemia Zinc Finger Protein
J. Virol.,
June 1, 2007;
81(11):
5607 - 5616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-A. Kim, S. Jiang, S. Seng, K. Cha, H. K. Avraham, and S. Avraham
The BTB domain of the nuclear matrix protein NRP/B is required for neurite outgrowth
J. Cell Sci.,
December 1, 2005;
118(23):
5537 - 5548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Guidez, L. Howell, M. Isalan, M. Cebrat, R. M. Alani, S. Ivins, I. Hormaeche, M. J. McConnell, S. Pierce, P. A. Cole, et al.
Histone Acetyltransferase Activity of p300 Is Required for Transcriptional Repression by the Promyelocytic Leukemia Zinc Finger Protein
Mol. Cell. Biol.,
July 1, 2005;
25(13):
5552 - 5566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ikeda, K. Yoshida, S. Tsukahara, Y. Sakamoto, H. Tanaka, K.-I. Furukawa, and I. Inoue
The Promyelotic Leukemia Zinc Finger Promotes Osteoblastic Differentiation of Human Mesenchymal Stem Cells as an Upstream Regulator of CBFA1
J. Biol. Chem.,
March 4, 2005;
280(9):
8523 - 8530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Takahashi, M. J. McConnell, H. Harigae, M. Kaku, T. Sasaki, A. M. Melnick, and J. D. Licht
The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRT
Blood,
June 15, 2004;
103(12):
4650 - 4658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dong, D. L. Stenoien, J. Qiu, M. A. Mancini, and D. J. Tweardy
Reduced Intranuclear Mobility of APL Fusion Proteins Accompanies Their Mislocalization and Results in Sequestration and Decreased Mobility of Retinoid X Receptor {alpha}
Mol. Cell. Biol.,
May 15, 2004;
24(10):
4465 - 4475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Parrado, M. Robledo, M. R. Moya-Quiles, L. A. Marin, C. Chomienne, R. A. Padua, and M. R. Alvarez-Lopez
The promyelocytic leukemia zinc finger protein down-regulates apoptosis and expression of the proapoptotic BID protein in lymphocytes
PNAS,
February 17, 2004;
101(7):
1898 - 1903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. McConnell, N. Chevallier, W. Berkofsky-Fessler, J. M. Giltnane, R. B. Malani, L. M. Staudt, and J. D. Licht
Growth Suppression by Acute Promyelocytic Leukemia-Associated Protein PLZF Is Mediated by Repression of c-myc Expression
Mol. Cell. Biol.,
December 15, 2003;
23(24):
9375 - 9388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Nanba, A. Mammoto, K. Hashimoto, and S. Higashiyama
Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF
J. Cell Biol.,
November 10, 2003;
163(3):
489 - 502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Fahnenstich, A. Nandy, K. Milde-Langosch, T. Schneider-Merck, N. Walther, and B. Gellersen
Promyelocytic leukaemia zinc finger protein (PLZF) is a glucocorticoid- and progesterone-induced transcription factor in human endometrial stromal cells and myometrial smooth muscle cells
Mol. Hum. Reprod.,
October 1, 2003;
9(10):
611 - 623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. McLoughlin, E. Ehler, G. Carlile, J. D. Licht, and B. W. Schafer
The LIM-only Protein DRAL/FHL2 Interacts with and Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein
J. Biol. Chem.,
September 27, 2002;
277(40):
37045 - 37053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-S. Dai, N. Chevallier, S. Stone, M. C. Heinrich, M. McConnell, T. Reuter, H. E. Broxmeyer, J. D. Licht, L. Lu, and M. E. Hoatlin
The Effects of the Fanconi Anemia Zinc Finger (FAZF) on Cell Cycle, Apoptosis, and Proliferation Are Differentiation Stage-specific
J. Biol. Chem.,
July 12, 2002;
277(29):
26327 - 26334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tsuzuki and T. Enver
Interactions of GATA-2 with the promyelocytic leukemia zinc finger (PLZF) protein, its homologue FAZF, and the t(11;17)-generated PLZF-retinoic acid receptor alpha oncoprotein
Blood,
May 1, 2002;
99(9):
3404 - 3410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Hummel, T. Zhang, R. A. Wells, and S. Kamel-Reid
The Retinoic Acid Receptor {alpha} (RAR{alpha}) Chimeric Proteins PML-, PLZF-, NPM-, and NuMA-RAR{alpha} Have Distinct Intracellular Localization Patterns
Cell Growth Differ.,
April 1, 2002;
13(4):
173 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Falini and D. Y. Mason
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
Blood,
January 15, 2002;
99(2):
409 - 426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. O. Ward, M. J. McConnell, G. W. Carlile, P. P. Pandolfi, J. D. Licht, and L. P. Freedman
The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D3-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D3 receptor
Blood,
December 1, 2001;
98(12):
3290 - 3300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Melnick, G. W. Carlile, M. J. McConnell, A. Polinger, S. W. Hiebert, and J. D. Licht
AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein
Blood,
December 1, 2000;
96(12):
3939 - 3947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Melnick, K. F. Ahmad, S. Arai, A. Polinger, H. Ball, K. L. Borden, G. W. Carlile, G. G. Prive, and J. D. Licht
In-Depth Mutational Analysis of the Promyelocytic Leukemia Zinc Finger BTB/POZ Domain Reveals Motifs and Residues Required for Biological and Transcriptional Functions
Mol. Cell. Biol.,
September 1, 2000;
20(17):
6550 - 6567.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. M. Melnick, J. J. Westendorf, A. Polinger, G. W. Carlile, S. Arai, H. J. Ball, B. Lutterbach, S. W. Hiebert, and J. D. Licht
The ETO Protein Disrupted in t(8;21)-Associated Acute Myeloid Leukemia Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein
Mol. Cell. Biol.,
March 15, 2000;
20(6):
2075 - 2086.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. E. Hoatlin, Y. Zhi, H. Ball, K. Silvey, A. Melnick, S. Stone, S. Arai, N. Hawe, G. Owen, A. Zelent, et al.
A Novel BTB/POZ Transcriptional Repressor Protein Interacts With the Fanconi Anemia Group C Protein and PLZF
Blood,
December 1, 1999;
94(11):
3737 - 3747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Zhang, H. Xiong, L.-X. Kan, C.-K. Zhang, X.-F. Jiao, G. Fu, Q.-H. Zhang, L. Lu, J.-H. Tong, B.-W. Gu, et al.
Genomic sequence, structural organization, molecular evolution, and aberrant rearrangement of promyelocytic leukemia zinc finger gene
PNAS,
September 28, 1999;
96(20):
11422 - 11427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Melnick and J. D. Licht
Deconstructing a Disease: RAR{alpha}, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia
Blood,
May 15, 1999;
93(10):
3167 - 3215.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Shaknovich, P. L. Yeyati, S. Ivins, A. Melnick, C. Lempert, S. Waxman, A. Zelent, and J. D. Licht
The Promyelocytic Leukemia Zinc Finger Protein Affects Myeloid Cell Growth, Differentiation, and Apoptosis
Mol. Cell. Biol.,
September 1, 1998;
18(9):
5533 - 5545.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Grimwade, P. Gorman, E. Duprez, K. Howe, S. Langabeer, F. Oliver, H. Walker, D. Culligan, J. Waters, M. Pomfret, et al.
Characterization of Cryptic Rearrangements and Variant Translocations in Acute Promyelocytic Leukemia
Blood,
December 15, 1997;
90(12):
4876 - 4885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Li, J. M. Lopez-Guisa, N. Ninan, E. J. Weiner, F. J. Rauscher III, and R. Marmorstein
Overexpression, Purification, Characterization, and Crystallization of the BTB/POZ Domain from the PLZF Oncoprotein
J. Biol. Chem.,
October 24, 1997;
272(43):
27324 - 27329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. M. Koken, A. Reid, F. Quignon, M. K. Chelbi-Alix, J. M. Davies, J. H. S. Kabarowski, J. Zhu, S. Dong, S.-J. Chen, Z. Chen, et al.
Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies
PNAS,
September 16, 1997;
94(19):
10255 - 10260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Y. Li, M. A. English, H. J. Ball, P. L. Yeyati, S. Waxman, and J. D. Licht
Sequence-specific DNA Binding and Transcriptional Regulation by the Promyelocytic Leukemia Zinc Finger Protein
J. Biol. Chem.,
September 5, 1997;
272(36):
22447 - 22455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Tenen, R. Hromas, J. D. Licht, and D.-E. Zhang
Transcription Factors, Normal Myeloid Development, and Leukemia
Blood,
July 15, 1997;
90(2):
489 - 519.
[Full Text]
[PDF]
|
 |
|
|
|